Susquehanna lowered the firm’s price target on Endava (DAVA) to $50 from $55. The firm noted the company’s CEO on the earnings call discussed leveraging their AI-enabled capabilities like Morpheus and Compass to accelerate client transformations and a solid pipeline, however he cautioned these large scale projects require business case validation and prolonged ideation.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DAVA:
- Endava Reports Q2 FY2025 Results and Share Buyback
- Endava: Despite Mixed Results, Strong US Market and Strategic Initiatives Reinforce Buy Rating
- Endava plc to Hold General Meeting to Approve $100 Million Share Repurchase Program
- Endava announces $100M share repurchase program
- Endava Announces Q2 Fiscal 2025 Results and $100 Million Share Repurchase Program